Hacker News
- Clinical Trial of HIV Vaccine Begins in United States and South Africa https://www.niaid.nih.gov/news-events/clinical-trial-hiv-vaccine-begins-united-states-and-south-africa 7 comments
- NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced Covid-19 https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19 13 comments
- NIH Scientists Identify Antibody That Neutralizes Nearly All HIV Strains https://www.niaid.nih.gov/news-events/nih-scientists-identify-potent-antibody-neutralizes-nearly-all-hiv-strains 139 comments
- Researchers observed rapid immune system changes in small study of people who switched to vegan or ketogenic (keto) diet. Vegan diet prompted responses linked to innate immunity while keto diet prompted responses associated with adaptive immunity. There were also shifts in gut microbiomes. https://www.niaid.nih.gov/news-events/switching-vegan-or-ketogenic-diet-rapidly-impacts-immune-system 42 comments science
- Clinical Trial of HIV Vaccine Begins in United States and South Africa https://www.niaid.nih.gov/news-events/clinical-trial-hiv-vaccine-begins-united-states-and-south-africa 21 comments health
- Universal Influenza Vaccine performs well in Phase 1 trail https://www.niaid.nih.gov/news-events/vrc-uni-flu-vax 15 comments futurology
- Universal Influenza Vaccine performs well in Phase 1 trail https://www.niaid.nih.gov/news-events/vrc-uni-flu-vax 280 comments science
- Experimental Cancer Vaccine Shows Promise in Animal Studies https://www.niaid.nih.gov/news-events/experimental-cancer-vaccine-shows-promise-animal-studies 2 comments health
- Fauci Submits Resignation. Effective December. https://www.niaid.nih.gov/news-events/statement-anthony-s-fauci-md 3 comments worldnews
- Food Allergy Is Associated with Lower Risk of SARS-CoV-2 Infection https://www.niaid.nih.gov/news-events/food-allergy-associated-lower-risk-sars-cov-2-infection 49 comments science
- Peanut allergy affects about 2% of children in the United States. A new study finds that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. https://www.niaid.nih.gov/news-events/oral-immunotherapy-induces-remission-peanut-allergy-some-young-children 12 comments science
- Peanut allergy affects about 2% of children in the United States. A new study finds that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. https://www.niaid.nih.gov/news-events/oral-immunotherapy-induces-remission-peanut-allergy-some-young-children 402 comments science
- An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates. This experimental mRNA vaccine combines several features that may overcome shortcomings of other experimental HIV vaccines. https://www.niaid.nih.gov/news-events/experimental-mrna-hiv-vaccine-safe-shows-promise-animals 67 comments science
- Hamster study evaluates airborne & fomite transmission of SARS-CoV-2. The study, published in Nature Communications, details the efficiency of airborne transmission between hamsters and examines how the virus replicates and causes disease throughout the respiratory system. https://www.niaid.nih.gov/news-events/nih-hamster-study-evaluates-airborne-and-fomite-transmission-sars-cov-2 5 comments science
- NIH scientists used bacteriophage viruses to successfully treat mice infected with multidrug-resistant Klebsiella pneumoniae, one of the biggest antibiotic resistance threats. Using viruses instead of antibiotics to treat drug-resistant bacteria is a promising strategy known as “phage therapy.” https://www.niaid.nih.gov/news-events/mouse-study-shows-bacteriophage-therapy-could-fight-drug-resistant-klebsiella 81 comments science
- An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study. The vaccine platform could be highly adaptable for use against other viruses including HIV and SARS-CoV-2. https://www.niaid.nih.gov/news-events/intranasal-influenza-vaccine-spurs-strong-immune-response-phase-1-study 31 comments science
- NIH Scientists Identify Nutrient that Helps Prevent Bacterial Infection. Taurine, which Helps the Body Digest Fats and Oils, Could Offer Treatment Benefit. https://www.niaid.nih.gov/news-events/nih-scientists-identify-nutrient-helps-prevent-bacterial-infection 8 comments science
- The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces. Scientists found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detectable in aerosols for up to three hours, up to four hours on copper, https://www.niaid.nih.gov/news-events/new-coronavirus-stable-hours-surfaces 37 comments science
- Study Vaccine Protects Monkeys Against Four Types of Hemorrhagic Fever Viruses. The vaccine was created using weakened vesicular stomatitis virus and proteins that elicit protective immune responses. The proteins are from Ebola virus, Sudan virus, Marburg virus and Lassa virus https://www.niaid.nih.gov/news-events/study-vaccine-protects-monkeys-against-four-types-hemorrhagic-fever-viruses 11 comments science
- Scientists newly identified set of three antibodies isolated from a person sick with the flu, and found that the antibodies provided broad protection against several different strains of influenza when tested both in vitro and in mice, which could become the basis for new antivirals and vaccines. https://www.niaid.nih.gov/news-events/broadly-protective-antibodies-could-lead-better-flu-treatments-and-vaccines 262 comments science
- Animals undergoing dietary restriction were better protected against tumors and bacterial infections than those with unrestricted diets. Researchers restricted diets of mice for up to four weeks and found they had more robust T cell immune responses and were better protected from illness and tumors. https://www.niaid.nih.gov/news-events/memory-t-cells-shelter-bone-marrow-boosting-immunity-mice-restricted-diets 5 comments science
- NIH researchers make progress toward Epstein-Barr virus (EBV) vaccine, with novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers. Worldwide, EBV-associated cancers results in 140,000 deaths. https://www.niaid.nih.gov/news-events/nih-researchers-make-progress-toward-epstein-barr-virus-vaccine 3 comments science
- A new NIH study unexpectedly found that a bacterium in probiotic supplements helps eliminate Staphylococcus aureus, a bacteria that can cause serious antibiotic-resistant infections. Then, using a mouse study model, the researchers identified exactly how that happens in the journal Nature. https://www.niaid.nih.gov/news-events/nih-study-finds-probiotic-bacillus-eliminates-staphylococcus-bacteria 4 comments science
- An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported today in the journal Nature Medicine. https://www.niaid.nih.gov/news-events/hiv-vaccine-elicits-antibodies-animals-neutralize-dozens-hiv-strains 23 comments science
- NIH Herpesvirus Study in Mice Leads to Discovery of Potential Broad-Spectrum Antiviral https://www.niaid.nih.gov/news-events/nih-herpesvirus-study-mice-leads-discovery-potential-broad-spectrum-antiviral 3 comments science
- New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis. https://www.niaid.nih.gov/news-events/stem-cell-transplants-may-induce-long-term-remission-multiple-sclerosis 6 comments science
- Scientists identify antibody from an HIV-infected person that potently neutralized 98% of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class. This makes it a candidate for further development to potentially treat or prevent HIV infection. https://www.niaid.nih.gov/news-events/nih-scientists-identify-potent-antibody-neutralizes-nearly-all-hiv-strains 7 comments science
- Media Availability: NIH-Led Team Discovers New HIV Vaccine Target https://www.niaid.nih.gov/news/newsreleases/2016/pages/hiv-1-fusion-peptide.aspx 4 comments science
- NIH Scientists Discover Genetic Cause of Rare Allergy to Vibration http://www.niaid.nih.gov/news/newsreleases/2016/pages/vibratoryurticaria.aspx 3 comments science
- Study Finds Peanut Consumption in Infancy May Prevent Peanut Allergy http://www.niaid.nih.gov/news/newsreleases/2015/pages/leap.aspx 36 comments science
- Estrogen worsens allergic reactions in mice http://www.niaid.nih.gov/news/newsreleases/2014/pages/allergygenderdisparity.aspx 10 comments science
- Scientists Develop Nasal Test for Human Prion Disease: A nasal brush test can rapidly and accurately diagnose Creutzfeldt-Jakob disease (CJD), an incurable and ultimately fatal neurodegenerative disorder, according to a study http://www.niaid.nih.gov/news/newsreleases/2014/pages/cjdtest.aspx 7 comments science
- HIV Vaccine Failure - Clinical trial of HVTN505 (Ad5-vectored HIV vaccine) halted early due to lack of efficacy and increase in HIV infection in vaccinees vs patients receiving placebo http://www.niaid.nih.gov/news/qa/pages/hvtn505qa2013.aspx 13 comments science
- Newly invented protein compound kills numerous viruses http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/draco.aspx 29 comments science
- HIV Study Named 2011 Breakthrough of the Year by Science http://www.niaid.nih.gov/news/newsreleases/2011/pages/hptn052breakthrough.aspx 58 comments science
- The Evidence That HIV Causes AIDS http://www.niaid.nih.gov/factsheets/evidhiv.htm 86 comments science